您当前的位置:
首页 >
文章列表页 >
Research on the development methodology for clinical practice guidelines for organic integration of traditional Chinese medicine and Western medicine
POSITION ARTICLE AND GUIDELINE | 更新时间:2025-12-13
上一篇|下一篇
    • Research on the development methodology for clinical practice guidelines for organic integration of traditional Chinese medicine and Western medicine

    • Research on the development methodology for clinical practice guidelines for organic integration of traditional Chinese medicine and Western medicine

    • Ying-Hui Jin ,Yan-Ping Wang ,Ying-Lan Xie ,Gui-Hua Tian ,Xiao-Yu Zhang ,Nan-Nan Shi ,Ke-Hu Yang ,Xin Sun ,Yao-Long Chen ,Da-Rong Wu ,Xin-Feng Guo ,Long Ge ,Chen Zhao ,Cheng Lu ,Yin Jiang ,Jing Guo ,Si-Yu Yan ,Yong-Bo Wang ,Qiao Huang ,Xiang-Ying Ren ,Ying-Yue Rao ,Yun-Yun Wang ,Meng-Qian Yuan ,Xian-Tao Zeng ,Hong-Cai Shang
    • MMR 2024年11卷第3期 页码:313-322
    • DOI: 10.1186/s40779-023-00481-9     

      中图分类号:

    移动端阅览

  •  
  •  
  • HTML全文

  • 图( 1 ) 表( 1 )

  • 参考文献

  • 出版信息

  • 数据统计

论文导航
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

106

浏览量

22

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Comparative study on the anti-tuberculous effect and mechanism of the traditional Chinese medicines NiuBeiXiaoHe extract and JieHeWan
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)
Treatment of rhubarb extracts on severe cerebral injury complications
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Engineering of functional auditory neurons from human induced pluripotent stem cells

相关作者

Yan Liang
Li-Yao Duan
Xue-Qiong Wu
Yue Zheng
Jun Liu
Yu-Mei Liang
Hong Lei
Zai-Xing Jia

相关机构

Hebei North University
Clinical Laboratory, the 8th Medical Center, Chinese PLA General Hospital
Pathology Department, the 8th Medical Center, Chinese PLA General Hospital
Guangdong Qifang Pharmaceutical Co., Ltd
Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Tuberculosis Research Institute, the 8th Medical Center, Chinese PLA General Hospital